Hans Eng is founder and chief executive officer of Eng3 Corporation. He formed Eng3 several years after moving to the United States from Germany.
Hans’ 25+ years of experience with advanced medical technologies includes Johnson & Johnson in Europe and the formation, growth, and successful sale of a German medical implant company. Hans has deep experience in research and development, production, and quality assurance for medical devices.
A degree from the Technical University of Berlin and his background in material sciences and proteomics enabled him to develop the proprietary technology that underlies Eng3’s NanoVi® products. Hans’ expertise in medical technologies and his passion for health and athletic performance are reflected in NanoVi® technology.